SCHEDULE 13D/A
Beneficial Ownership Report
Atara Biotherapeutics, Inc. Filed Acc 0001104659-26-061506
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Redmile Group, LLC | 950,994 | 9.9% |
| Jeremy C. Green | 950,994 | 9.9% |
| Redmile Biopharma Investments II, L.P. | 651,924 | 6.9% |
| Redmile Strategic Long Only Trading Sub, Ltd. | 576,148 | 6.1% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-08-14 SCHEDULE 13G/A · Point72 Asset Management, L.P. 7.6%
- 2026-07-24 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
- 2026-05-14 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
- 2026-05-13 SCHEDULE 13G · Adage Capital Management, L.P. 8.56%
- 2026-05-11 SCHEDULE 13D/A · Panacea Innovation Limited 16.1%
- 2026-05-08 SCHEDULE 13G · Point72 Asset Management, L.P. 6.2%
- 2026-05-07 SCHEDULE 13G/A · EcoR1 Capital, LLC 17.4%
- 2026-01-14 SCHEDULE 13D/A · Panacea Innovation Limited 19.99%
- 2025-11-14 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
- 2025-11-14 SCHEDULE 13G/A · EcoR1 Capital, LLC 9.9%
- 2025-08-19 SCHEDULE 13D/A · Panacea Innovation Limited 20.0%
- 2025-05-23 SCHEDULE 13D · Redmile Group, LLC 9.9%
- 2025-05-21 SCHEDULE 13D · Panacea Innovation Limited 19.99%
- 2025-05-16 SCHEDULE 13D/A · Adiumentum Capital Fund I LP 19.99%
- 2025-05-15 SCHEDULE 13G/A · Redmile Group, LLC 9.9%
- 2025-02-06 SCHEDULE 13G · Panacea Venture Healthcare Fund II, L.P. 9.5%
- 2024-11-14 SC 13G/A · Citadel Advisors LLC 4.6%
- 2024-11-14 SC 13G/A · EcoR1 Capital, LLC 9.99%
- 2024-11-12 SC 13G/A · The Vanguard Group 3.18%
- 2024-11-04 SC 13G/A · The Vanguard Group 3.18%
Loading xslSCHEDULE_13D_X02/primary_doc.xml…